Search results
Results from the WOW.Com Content Network
Two-time defending champion Novak Djokovic [1] defeated Daniil Medvedev in the final, 7–5, 6–2, 6–2 to win the men's singles tennis title at the 2021 Australian Open. [2] It was his record-extending ninth Australian Open title and his 18th major title overall. [3]
Matches on main courts; Matches on Rod Laver Arena; Event Winner Loser Score Women's Singles 1st Round: Sofia Kenin [4]: Maddison Inglis [WC] : 7–5, 6–4 Women's Singles 1st Round
The LUNSERS is designed to monitor medication-induced side effects. This psychiatric assessment tools allows for the monitoring of side effects related to neuroleptic (or anti-psychotic) medications. The test is a self-reported check-tick box format with a predefined scale from "not at all" to "very much".
The Global Appraisal of Individual Needs (GAIN) is a family of evidence-based instruments used to assist clinicians with diagnosis, placement, and treatment planning. The GAIN is used with both adolescents and adults in all kinds of treatment programs, including outpatient, intensive outpatient, partial hospitalization, methadone, short-term residential, long-term residential, therapeutic ...
Other assessment tools may focus on a specific aspect of the patient's care. For example, the Waterlow score and the Braden scale deals with a patient's risk of developing a Pressure ulcer (decubitus ulcer), the Glasgow Coma Scale measures the conscious state of a person, and various pain scales exist to assess the "fifth vital sign".
The CRAFFT [1] is a short clinical assessment tool designed to screen for substance-related risks and problems in adolescents. CRAFFT stands for the key words of the 6 items in the second section of the assessment - Car, Relax, Alone, Forget, Friends, Trouble. As of 2020, updated versions of the CRAFFT known as the "CRAFFT 2.1" and "CRAFFT 2.1 ...
In psychometrics, item response theory (IRT, also known as latent trait theory, strong true score theory, or modern mental test theory) is a paradigm for the design, analysis, and scoring of tests, questionnaires, and similar instruments measuring abilities, attitudes, or other variables.
Based on the results of a 2019 Cochrane meta-analysis of available studies the ACE-III should only be used as an adjunct to a full clinical assessment and not alone for the screening of dementia or mild cognitive impairment in patients presenting with or at risk for cognitive decline. [14]